Immunomodulatory drugs

30 Immunomodulatory drugs




The immune system has evolved to provide humoral (antibody) and cell-mediated immunity against foreign pathogens (e.g. bacteria, fungus, virus and parasites, but also foreign grafts) and malignancy (cancer); it can also act against self-antigens in pathological conditions (autoimmune disease). A variety of immunocompetent cells, including antigen-presenting cells and T and B lymphocytes, orchestrate the manner in which the body responds to a particular insult (Fig. 3.30.1). Drugs that target the immune cells are of immense benefit in the treatment of a number of diseases that involve overactivity of the immune system (Table 3.30.1) or imbalance (e.g. balance of T helper cell types affects progression of leprosy). The pharmacology of these agents in the context of rheumatoid arthritis will be used as an example.



Table 3.30.1 T cells in disease























Cell type Normal role Inappropriate deployment
T helper 1 Proliferation of CD8 cells, macrophages Rheumatoid arthritis, tuberculosis, type 1 diabetes mellitus, multiple sclerosis, Helicobacter pylori-induced peptic ulcer
T helper 2 Response to extra-cellular antigens, driving antibody production from B cells Allergy, asthma, schistosome infection
Cytotoxic T cells Removal of cells with intracellular foreign protein production (malignant cells, transplant cells, viruses) Toxic shock (over-expansion in response to bacterial endotoxins), Kawasaki disease (blood vessel inflammation)
B cells Production of anti-bodies to foreign antigens Autoimmune thyroiditis, agranulocytosis initiated by drugs


Rheumatoid arthritis


Rheumatoid arthritis is a chronic inflammatory disease associated with swollen and painful joints, stiffness in the morning and cartilage and bone erosion. The disease is characterized by an inflamed synovial membrane, infiltration of T lymphocytes and macrophages, and deposition of rheumatoid factor and immune complexes. The production of a range of mediators, including prostaglandins, results in pain and swelling of the synovium; cytokines produced by macrophages and T lymphocytes stimulate a variety of cells (osteoclast, synoviocytes, endothelial cells) and ultimately give rise to bone and cartilage destruction. A variety of agents are used in the treatment of rheumatoid arthritis and include immunosuppressants (ciclosporin, glucocorticosteroids), the disease-modifying anti-arthritic drugs (DMARDs; gold, D-penicillamine, sulfasalazine, hydroxychloroquine and leflunomide), cytotoxic agents (azathioprine, methotrexate, cyclophosphamide) and biological agents (monoclonal antibodies against tumour necrosis factor (TNF) and interleukin (IL-1)).



Non-steroidal anti-inflammatory drugs


Non-selective (e.g. ibuprofen, aspirin, indometacin) and COX2-selective (e.g. celecoxib) NSAIDs inhibit the synthesis of prostaglandins (Ch. 29) implicated in the pain and swelling associated with rheumatoid arthritis. These drugs only provide symptomatic relief and do not prevent destruction of cartilage and bone.

< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 18, 2016 | Posted by in PHARMACY | Comments Off on Immunomodulatory drugs

Full access? Get Clinical Tree

Get Clinical Tree app for offline access